Are Manufacturers Willing To Do Outcomes-Based Pricing? Payers Are Skeptical
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA/CMS Summit speakers say they've yet to see any real interest from manufacturers in putting money at risk if their products don't meet outcome measures.